Gut microbiota and metabolites of α-synuclein transgenic monkey models with early stage of Parkinson’s disease
Abstract Parkinson’s disease (PD) is the second most prevalent neurodegenerative disease. However, it is unclear whether microbiota and metabolites have demonstrated changes at early PD due to the difficulties in diagnosis and identification of early PD in clinical practice. In a previous study, we...
Main Authors: | Yaping Yan, Shuchao Ren, Yanchao Duan, Chenyu Lu, Yuyu Niu, Zhengbo Wang, Briauna Inglis, Weizhi Ji, Yun Zheng, Wei Si |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-09-01
|
Series: | npj Biofilms and Microbiomes |
Online Access: | https://doi.org/10.1038/s41522-021-00242-3 |
Similar Items
-
Histopathological Features and Composition of Gut Microbiota in Rhesus Monkey of Alcoholic Liver Disease
by: Hong Wang, et al.
Published: (2019-02-01) -
Age-associated increases of α-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion: Is this the target for Parkinson's disease?
by: Yaping Chu, et al.
Published: (2007-01-01) -
Fate of Antioxidants in Gut and Interaction of Gut Metabolites and Gut Microbiota
Published: (2023) -
Impact of Gut Microbiota and Microbiota-Related Metabolites on Hyperlipidemia
by: Xiaokang Jia, et al.
Published: (2021-08-01) -
Gut microbiota, metabolites, and cardiovascular diseases
by: Yi-Qiong Zhang, et al.
Published: (2021-01-01)